204 related articles for article (PubMed ID: 19469866)
1. Expression of retinoic acid receptor beta in dermatofibrosarcoma protuberans.
Xiaoli Z; Qinhe F
J Cutan Pathol; 2009 Nov; 36(11):1141-5. PubMed ID: 19469866
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 expression in dermatofibroma and dermatofibrosarcoma protuberans.
Adler N; Tsabari C; Sulkes J; Ad-El D; Feinmesser M
J Cutan Pathol; 2008 Jun; 35(6):532-5. PubMed ID: 18201240
[TBL] [Abstract][Full Text] [Related]
3. A study of CD117 expression in dermatofibrosarcoma protuberans and cellular dermatofibroma.
Labonte S; Hanna W; Bandarchi-Chamkhaleh B
J Cutan Pathol; 2007 Nov; 34(11):857-60. PubMed ID: 17944726
[TBL] [Abstract][Full Text] [Related]
4. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans.
Kubo M; Ihn H; Yamane K; Tamaki K
Br J Dermatol; 2006 May; 154(5):919-25. PubMed ID: 16634896
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromatous changes in dermatofibrosarcoma protuberans: a potential pitfall in the diagnosis of a serious cutaneous soft tissue neoplasm.
Kovarik CL; Hsu MY; Cockerell CJ
J Cutan Pathol; 2004 Aug; 31(7):492-6. PubMed ID: 15239679
[TBL] [Abstract][Full Text] [Related]
6. Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-beta 2 expression.
Song S; Lippman SM; Zou Y; Ye X; Ajani JA; Xu XC
Oncogene; 2005 Dec; 24(56):8268-76. PubMed ID: 16170369
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa.
Sachdev R; Sundram U
J Cutan Pathol; 2006 May; 33(5):353-60. PubMed ID: 16640542
[TBL] [Abstract][Full Text] [Related]
8. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
Kahn HJ; Fekete E; From L
Hum Pathol; 2001 Jan; 32(1):50-6. PubMed ID: 11172295
[TBL] [Abstract][Full Text] [Related]
9. Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans.
Linn SC; West RB; Pollack JR; Zhu S; Hernandez-Boussard T; Nielsen TO; Rubin BP; Patel R; Goldblum JR; Siegmund D; Botstein D; Brown PO; Gilks CB; van de Rijn M
Am J Pathol; 2003 Dec; 163(6):2383-95. PubMed ID: 14633610
[TBL] [Abstract][Full Text] [Related]
10. Dermatofibrosarcoma protuberans presenting as a subcutaneous mass: a clinicopathological study of 15 cases with exclusive or near-exclusive subcutaneous involvement.
Bague S; Folpe AL
Am J Dermatopathol; 2008 Aug; 30(4):327-32. PubMed ID: 18645303
[TBL] [Abstract][Full Text] [Related]
11. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays.
Patel KU; Szabo SS; Hernandez VS; Prieto VG; Abruzzo LV; Lazar AJ; López-Terrada D
Hum Pathol; 2008 Feb; 39(2):184-93. PubMed ID: 17950782
[TBL] [Abstract][Full Text] [Related]
12. Myxoid dermatofibrosarcoma protuberans: a rare variant analyzed in a series of 23 cases.
Reimann JD; Fletcher CD
Am J Surg Pathol; 2007 Sep; 31(9):1371-7. PubMed ID: 17721193
[TBL] [Abstract][Full Text] [Related]
13. Expression of nestin in dermatofibrosarcoma protuberans in comparison to dermatofibroma.
Mori T; Misago N; Yamamoto O; Toda S; Narisawa Y
J Dermatol; 2008 Jul; 35(7):419-25. PubMed ID: 18705829
[TBL] [Abstract][Full Text] [Related]
14. IGFBP7, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans.
Li J; Yu Y; Yang Y; Wang L; Cao J; Liang X; Xiao X; Tu Y; Chen H
J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):382-5. PubMed ID: 21492256
[TBL] [Abstract][Full Text] [Related]
15. Dermatofibrosarcoma protuberans: clinical, pathological, and genetic (COL1A1-PDGFB ) study with therapeutic implications.
Llombart B; Sanmartín O; López-Guerrero JA; Monteagudo C; Serra C; Requena C; Poveda A; Vistós JL; Almenar S; Llombart-Bosch A; Guillén C
Histopathology; 2009 Jun; 54(7):860-72. PubMed ID: 19635106
[TBL] [Abstract][Full Text] [Related]
16. Expression of retinoic acid receptors in human endometrial carcinoma.
Tanabe K; Utsunomiya H; Tamura M; Niikura H; Takano T; Yoshinaga K; Nagase S; Suzuki T; Ito K; Matsumoto M; Hayashi S; Yaegashi N
Cancer Sci; 2008 Feb; 99(2):267-71. PubMed ID: 18271925
[TBL] [Abstract][Full Text] [Related]
17. Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
Kim HJ; Lee JY; Kim SH; Seo YJ; Lee JH; Park JK; Kim MH; Cinn YW; Cho KH; Yoon TY
Br J Dermatol; 2007 Aug; 157(2):319-24. PubMed ID: 17596171
[TBL] [Abstract][Full Text] [Related]
18. Dermatofibrosarcoma protuberans with EMa+ cells. Report of a case suggesting perineurial cell differentiation.
Zamecnik M; Michal M; Baumruk L; Mukensnabl P
Pathol Res Pract; 2002; 198(11):767-74; discussion 775. PubMed ID: 12530581
[TBL] [Abstract][Full Text] [Related]
19. Clinical variants of the preprotuberant stage of dermatofibrosarcoma protuberans.
Martin L; Piette F; Blanc P; Mortier L; Avril MF; Delaunay MM; Dréno B; Granel F; Mantoux F; Aubin F; Sassolas B; Adamski H; Dalac S; Pauwels C; Dompmartin A; Lok C; Estève E; Guillot B;
Br J Dermatol; 2005 Nov; 153(5):932-6. PubMed ID: 16225602
[TBL] [Abstract][Full Text] [Related]
20. Pigmented dermatofibrosarcoma protuberans with prominent meningothelial-like whorls.
Wang J; Yang W
J Cutan Pathol; 2008 Oct; 35 Suppl 1():65-9. PubMed ID: 18544057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
